데이터가 없습니다.

1. Value of cardiopulmonary exercise testing in the assessment of symptoms and quality of life in Asian patients with chronic obstructive pulmonary disease [ JOURNAL OF THORACIC DISEASE ] - 2023.07.31
2. Comparison of Predicted Exercise Capacity Equations in Adult Korean Subjects [ JOURNAL OF KOREAN MEDICAL SCIENCE ] - 2022.04.13
3. Distinctive patterns of pulmonary function change according to baseline lung volume and diffusing capacity [ INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE ] - 2020.06.01
4. Hyperuricemia Is Not Predictive of Long-Term Outcome in Patients with Stable Chronic Obstructive Pulmonary Disease [ JOURNAL OF KOREAN MEDICAL SCIENCE ] - 2020.03.02
5. Safety of early orthopedic surgery in patients with intermediate/low- or low-risk pulmonary embolism [ JOURNAL OF THORACIC DISEASE ] - 2020.03.01
6. Epidemiology of Antiphospholipid Syndrome in Korea: a Nationwide Population-based Study [ JOURNAL OF KOREAN MEDICAL SCIENCE ] - 2020.02.10
7. Comparison of rivaroxaban and dalteparin for the long-term treatment of venous thromboembolism in patients with gynecologic cancers. [ Journal of Gynecologic Oncology ] - 2020.01.01
8. Prognostic value of blood biomarkers in patients with unprovoked acute pulmonary embolism [ ANNALS OF THORACIC MEDICINE ] - 2019.10.01
9. A Retrospective Study on Efficacy and Safety of Rivaroxaban and Dalteparin for Long-Term Treatment of Venous Thromboembolism in Patients with Lung Cancer [ RESPIRATION ] - 2019.09.01
10. Association of plasma fibrinogen concentrations and blood eosinophil counts with clinical phenotypes of COPD [ INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE ] - 2019.09.01
11. Clinical Phenotypes, Comorbidities, and Exacerbations according to Serum 25-OH Vitamin D and Plasma Fibrinogen Levels in Chronic Obstructive Pulmonary Disease [ JOURNAL OF KOREAN MEDICAL SCIENCE ] - 2019.07.29
12. Rivaroxaban versus Low-Molecular-Weight Heparin for Venous Thromboembolism in Gastrointestinal and Pancreatobiliary Cancer [ JOURNAL OF KOREAN MEDICAL SCIENCE ] - 2019.06.03
13. Central extracorporeal membrane oxygenation and early rehabilitation for persistent severe pulmonary hypertension following pulmonary endarterectomy [ Acute and Critical Care ] - 2019.05.01
14. Glycoprotein IIb/IIIa receptor imaging with 18F-GP1 positron emission tomography for acute venous thromboembolism: an open-label, non-randomized, first-in-human phase 1 study [ JOURNAL OF NUCLEAR MEDICINE ] - 2019.02.01
15. The effect of a multidisciplinary team on the implementation rates of major diagnostic and therapeutic procedures of chronic thromboembolic pulmonary hypertension [ HEART LUNG ] - 2019.01.01
16. Clinical Phenotype of a First Unprovoked Acute Pulmonary Embolism Associated with Antiphospholipid Antibody Syndrome [ Tuberculosis and Respiratory Diseases(결핵 및 호흡기질환) ] - 2019.01.01
17. Effect of post-filter anticoagulation on mortality in patients with cancer-associated pulmonary embolism [ INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY ] - 2018.10.01
18. Fibrinogen as a potential biomarker for clinical phenotype in patients with chronic obstructive pulmonary disease [ JOURNAL OF THORACIC DISEASE ] - 2018.09.01
19. Practice patterns of retrievable inferior vena cava filters and predictors of filter retrieval in patients with pulmonary embolism. [ VASCULAR MEDICINE ] - 2017.12.01
20. 18F-FDG PET/CT를 통해 진단된 주폐동맥 협착 소견의 폐동맥 육종 [ Yeungnam University Journal of Medicine ] - 2017.12.01
21. Long-term outcomes of surgery for chronic thromboembolic pulmonary hypertension compared with medical therapy at a single Korean center [ KOREAN JOURNAL OF INTERNAL MEDICINE ] - 2017.09.01
22. Recurrent pulmonary embolism during dabigatran treatment in a patient with immune thrombocytopenic purpura. [ THROMBOSIS RESEARCH ] - 2016.12.01
23. Clinical Characteristics and Treatment Outcomes of Primary Pulmonary Artery Sarcoma in Korea. [ JOURNAL OF KOREAN MEDICAL SCIENCE ] - 2016.11.01
24. Efficacy and Safety of Roflumilast in Korean Patients with COPD. [ YONSEI MEDICAL JOURNAL ] - 2016.07.01
25. Pharmacological treatment response according to the severity of symptoms in patients with chronic obstructive pulmonary disease [ JOURNAL OF THORACIC DISEASE ] - 2015.10.01
26. Underrated value of repeated right heart catheterization in pulmonary hypertension with heart failure-a case of persisted pulmonary arterial hypertension after treatment for biventricular failure. [ JOURNAL OF THORACIC DISEASE ] - 2015.10.01
27. Improved survival of Korean patients with idiopathic pulmonary arterial hypertension after the introduction of targeted therapies [ HEART & LUNG ] - 2014.11.01
28. Longitudinal Lung Volume Changes in Patients with Chronic Obstructive Pulmonary Disease [ LUNG ] - 2013.05.29
29. Response patterns to bronchodilator and quantitative computed tomography in chronic obstructive pulmonary disease [ CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING ] - 2012.01.01
30. Different therapeutic responses in chronic obstructive pulmonary disease subgroups [ INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE ] - 2011.08.01
31. Predictors of pulmonary function response to treatment with salmeterol/fluticasone in patients with chronic obstructive pulmonary disease [ JOURNAL OF KOREAN MEDICAL SCIENCE ] - 2011.03.26

1. 수술이 불가능하거나 수술적 및/또는 중재적 치료 후 지속되는/재발한 만성 혈전색전성 폐고혈압 시험대상자에서 표준 요법에 대한 추가 요법으로서 셀렉시팍(selexipag)의 유효성 및 안전성을 평가하는 다기관, 무작위배정, 이중 눈가림, 위약 대조, 평행군, 집단 축차, 적 - 2019.01.18 ~ 2025.06.30
2. 수술이 불가능하거나 수술적 치료 후 지속되는/재발한 만성 혈전색전성 폐고혈압 시험대상자에서 표준 요법에 대한 추가 요법으로서 셀렉시팍(selexipag)의 유효성 및 안전성을 평가 - 2018.12.17 ~ 2025.06.30
3. Bayer임상시험에서 riociguat로 치료받은 폐동맥 고혈압(PAH) 환자에 대한 riociguat 경구투여의 공개, 다국가, 다기관, 단일군, 비대조, 장기 연장 시험 - 2018.10.08 ~ 2021.12.31
4. 일상진료 하에서 한국인 환자를 대상으로 볼리브리스의 안전성과 유효성을 관찰하기 위한 공개, 다기관, 사용성적조사 - 2016.07.28 ~ 2021.08.30
5. COPD 영상, 임상, 유전체 연관 연구를 통한 아형 발굴 - 2016.01.01 ~ 2016.12.31
6. 수술이 불가능한 만성 혈전색전성 폐 고혈압 시험대상자를 대상으로 마시텐탄의 유효성, 안전성 및 내약성을 평가하는 전향적, 무작위배정, 위약-대조, 이중-눈가림, 다기관, 평행군, 24-주 시험 - 2015.07.06 ~ 2016.06.30

데이터가 없습니다.

      데이터가 없습니다.

 공지